Found: 14
Select item for more details and to access through your institution.
Pathway-based analysis of primary biliary cirrhosis genome-wide association studies.
- Published in:
- Genes & Immunity, 2013, v. 14, n. 3, p. 179, doi. 10.1038/gene.2013.1
- By:
- Publication type:
- Article
Association of primary biliary cirrhosis with variants in the CLEC16A, SOCS1, SPIB and SIAE immunomodulatory genes.
- Published in:
- Genes & Immunity, 2012, v. 13, n. 4, p. 328, doi. 10.1038/gene.2011.89
- By:
- Publication type:
- Article
Gilbert's syndrome: an overview for clinical biochemists.
- Published in:
- Annals of Clinical Biochemistry, 2006, v. 43, n. 5, p. 340, doi. 10.1258/000456306778520034
- By:
- Publication type:
- Article
Low-dose interleukin-2 promotes STAT-5 phosphorylation, T<sub>reg</sub> survival and CTLA-4-dependent function in autoimmune liver diseases.
- Published in:
- Clinical & Experimental Immunology, 2017, v. 188, n. 3, p. 394, doi. 10.1111/cei.12940
- By:
- Publication type:
- Article
HLA haplotypes in primary sclerosing cholangitis patients of admixed and non-European ancestry.
- Published in:
- HLA: Immune Response Genetics, 2017, v. 90, n. 4, p. 228, doi. 10.1111/tan.13076
- By:
- Publication type:
- Article
The impact of ileal pouch‐anal anastomosis on graft survival following liver transplantation for primary sclerosing cholangitis.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2018, v. 48, n. 3, p. 322, doi. 10.1111/apt.14828
- By:
- Publication type:
- Article
Low risk of hepatotoxicity from rifampicin when used for cholestatic pruritus: a cross‐disease cohort study.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2018, v. 47, n. 8, p. 1213, doi. 10.1111/apt.14579
- By:
- Publication type:
- Article
Utility and cost evaluation of multiparametric magnetic resonance imaging for the assessment of non‐alcoholic fatty liver disease.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2018, v. 47, n. 5, p. 631, doi. 10.1111/apt.14469
- By:
- Publication type:
- Article
Expert clinical management of autoimmune hepatitis in the real world.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2017, v. 45, n. 5, p. 723, doi. 10.1111/apt.13907
- By:
- Publication type:
- Article
The inter-relationship of symptom severity and quality of life in 2055 patients with primary biliary cholangitis.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2016, v. 44, n. 10, p. 1039, doi. 10.1111/apt.13794
- By:
- Publication type:
- Article
Editorial: autoimmune hepatitis - identifying options for treatment.
- Published in:
- 2016
- By:
- Publication type:
- Editorial
Combined ursodeoxycholic acid (UDCA) and fenofibrate in primary biliary cholangitis patients with incomplete UDCA response may improve outcomes.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2016, v. 43, n. 2, p. 283, doi. 10.1111/apt.13465
- By:
- Publication type:
- Article
A comprehensive assessment of environmental exposures among 1000 North American patients with primary sclerosing cholangitis, with and without inflammatory bowel disease.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2015, v. 41, n. 10, p. 980, doi. 10.1111/apt.13154
- By:
- Publication type:
- Article
Review article: overlap syndromes and autoimmune liver disease.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2012, v. 36, n. 6, p. 517, doi. 10.1111/j.1365-2036.2012.05223.x
- By:
- Publication type:
- Article